DiscoverThe Rounds TableEpisode 117 - Brensocatib for Bronchiectasis and Alteplase for Posterior Circulation Ischemic Stroke
Episode 117 - Brensocatib for Bronchiectasis and Alteplase for Posterior Circulation Ischemic Stroke

Episode 117 - Brensocatib for Bronchiectasis and Alteplase for Posterior Circulation Ischemic Stroke

Update: 2025-05-08
Share

Description

Send us a text

Welcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast. This week, Dr. Mike Fralick and special guest Dr. Laiya Carayannopoulos from the Intern at Work Podcast and our Medicine Pods collaboration discuss two recent papers: the use of brensocatib (a DPP-1 inhibitor) to treat bronchiectasis, and the effect of alteplase administered 4.5 to 24 hours after stroke in patients with mild posterior circulation stroke who did not receive thrombectomy. Two papers, here we go!

  1. Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (0:0012:46 )
  2. Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours (12:4724:55 )

And for the Good Stuff (24:5626:08 ):

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 117 - Brensocatib for Bronchiectasis and Alteplase for Posterior Circulation Ischemic Stroke

Episode 117 - Brensocatib for Bronchiectasis and Alteplase for Posterior Circulation Ischemic Stroke

Dr. John Fralick and Dr. Michael Fralick